CN114716454A - Nitrogen and oxa condensed ring aromatic hydrocarbon and synthetic method thereof - Google Patents

Nitrogen and oxa condensed ring aromatic hydrocarbon and synthetic method thereof Download PDF

Info

Publication number
CN114716454A
CN114716454A CN202210557098.5A CN202210557098A CN114716454A CN 114716454 A CN114716454 A CN 114716454A CN 202210557098 A CN202210557098 A CN 202210557098A CN 114716454 A CN114716454 A CN 114716454A
Authority
CN
China
Prior art keywords
nitrogen
compound
ring aromatic
condensed ring
oxa
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN202210557098.5A
Other languages
Chinese (zh)
Inventor
樊良鑫
张静静
杨西发
刘向阳
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henan Agricultural University
Original Assignee
Henan Agricultural University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henan Agricultural University filed Critical Henan Agricultural University
Priority to CN202210557098.5A priority Critical patent/CN114716454A/en
Publication of CN114716454A publication Critical patent/CN114716454A/en
Priority to CN202310563635.1A priority patent/CN116836180A/en
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/06Peri-condensed systems
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/06Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64Fluorescence; Phosphorescence
    • G01N21/6428Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1029Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
    • C09K2211/1033Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom with oxygen
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02EREDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
    • Y02E10/00Energy generation through renewable energy sources
    • Y02E10/50Photovoltaic [PV] energy
    • Y02E10/549Organic PV cells

Abstract

The invention provides nitrogen and oxa condensed ring aromatic hydrocarbons and a synthesis method thereof, which are used for solving the technical problems of single synthesis method of the existing condensed ring aromatic hydrocarbons, complex substrate synthesis, limited product structure and the like. The synthesis method comprises the following steps: adding the oxazine compound 1, the diazo compound 2, the catalyst and the additive into a solvent in an inert atmosphere, reacting in the inert atmosphere, and obtaining the hetero-condensed ring aromatic compound 3 after the reaction is finished. The invention provides a simple and effective synthesis method for the synthesis of polycyclic aromatic hydrocarbon containing multiple heteroatoms, and the method has the characteristics of mild reaction conditions, simple operation, atom economy, economic steps, strong functional group tolerance, good yield and the like. The obtained product has wide industrial application prospect, and provides a new idea and a new method for the fields of medicine, natural product synthesis, luminescent materials and the like.

Description

Nitrogen and oxa condensed ring aromatic hydrocarbon and synthetic method thereof
Technical Field
The invention belongs to the technical field of organic synthetic chemistry, and particularly relates to nitrogen and oxa condensed ring aromatic hydrocarbon and a synthetic method thereof.
Background
Polycyclic aromatic hydrocarbons refer to polycyclic aromatic hydrocarbon compounds composed of two or more aromatic hydrocarbons and are widely used in the industries of medicines, dyes and the like. The crystal arrangement of the polycyclic aromatic hydrocarbon has pi-pi interaction, and molecules form ordered accumulation, so the polycyclic aromatic hydrocarbon has wide application prospects in the fields of Organic photoelectric devices (including Organic Field-Effect transistors (OFETs), Organic Solar Cells (OSCs), Organic Light-Emitting diodes (OLEDs) and the like), Organic semiconductor materials and the like (chem.Rev.,2007,107,926; chem.Soc.Rev.,2010,39, 1489; chem.Soc.Rev.,2012,41, 4245; Nature,2004,428,911). Compared with the traditional inorganic photoelectric material, the large-size conjugated molecule has the structural adjustment of molecular level; the solubility is good, and the processing is easy; the material is light and flexible, and can realize the preparation of large-area devices. Therefore, designing and synthesizing novel organic polycyclic aromatic hydrocarbons, and researching their properties and applications have been one of the research hotspots of scientists in the fields of chemistry, materials, biology and the like. In particular, the heteroatom is used for replacing part of carbon atoms in the polycyclic compound to form conjugated skeleton molecules containing the heteroatom, namely hetero-polycyclic aromatic hydrocarbon, so that the stability and the assembly performance of the material can be obviously improved, and the photoelectric performance and the versatility of the organic photoelectric material can be obviously improved (Angew. chem., int. Ed.,2010,49, 8209; chem. Mater.,2015,28, 3). Meanwhile, multifunctional modification of polycyclic aromatic hydrocarbon is also an important means for endowing organic photoelectric molecules with controllability and diversity.
The direct functionalization of inert C-H bonds is now undisputed as the ideal synthetic approach for chemists because of the superiority of the high atomic economy and the economic process, and it is called "Saint glass of chemistry". Indeed, transition metal catalyzed C — H activation reactions have achieved significant success over the last 20 years, achieving conversions not achievable by many traditional chemistries. Wherein, rhodium is catalyzed and guided to C-H bond activation 1: 2, the synthesis of polycyclic aromatic hydrocarbon constructed by coupling is rapidly developed, and a large number of novel polycyclic aromatic hydrocarbon frameworks with important application prospects in the fields of organic photoelectric materials and medicines are prepared. And the diazo compound is used as an important intermediate in organic synthesis and applied to transition metal catalysis 1: 2 coupling and constructing fused heterocyclic aromatic hydrocarbon is still in the initial stage. To date, rhodium catalyzed directed C-H activation 1: 2 coupling construction of fused ring arene molecules there is only one report (org. lett.2017,19,2294) and the study is relatively slow. The method takes a strongly coordinated pyridine compound as a guide group, and realizes the reaction with a diazo compound of 1: 2, coupling to construct a series of naphthoquinolinone skeletons.
On one hand, the guide group used by the existing synthesis means is pyridine with strong coordination capacity, the substrate synthesis is complex, the product type is single, and the obtained skeleton is only aza polycyclic aromatic hydrocarbon. On the other hand, the benzoxazine imine is used as a key intermediate in organic synthesis, and has simple synthesis and wide sources. It was applied as a weak directing group to rhodium-catalyzed carbene 1: 2 coupling studies have not been reported. According to the reports of the prior documents, the hetero-polycyclic aromatic hydrocarbon can obviously improve the stability and the assembly performance of the material, thereby obviously improving the photoelectric performance and the versatility of the organic photoelectric material (Angew. chem., int.Ed.,2010,49, 8209; chem. Mater.,2015,28,3), and the application of the hetero-polycyclic aromatic hydrocarbon in the aspect of the organic photoelectric material has wide prospect; therefore, a new method for synthesizing hetero-polycyclic aromatic hydrocarbons is urgently needed.
Disclosure of Invention
The invention provides nitrogen and oxa polycyclic aromatic hydrocarbon and a synthesis method thereof, and provides a simple and effective synthesis method for synthesis of polycyclic aromatic hydrocarbon containing multiple heteroatoms, aiming at the technical problems of single synthesis method of fused heterocyclic aromatic hydrocarbon, complex substrate synthesis, limited product structure and the like.
In order to achieve the purpose, the technical scheme of the invention is realized as follows:
a nitrogen and oxygen fused ring aromatic hydrocarbon has a structural formula as follows:
Figure BDA0003652662540000021
wherein R is any one of H, Me, OMe, F, Cl or Br; r1Any one of Me, n-Pr or Ph; r2Is n-Am oriPr; ar is Me, OMe, F, Cl, Br, Ph or CF3Any substituted benzene ring.
The synthesis method of the nitrogen and oxa condensed ring aromatic hydrocarbon comprises the following steps: adding an oxazine compound 1, a diazo compound 2, a catalyst and an additive into a solvent under an inert atmosphere for reaction, and obtaining a fused heterocyclic aromatic compound 3 after the reaction is finished, wherein the reaction equation is as follows:
Figure BDA0003652662540000022
wherein R is any one of H, Me, OMe, F, Cl or Br; r1Any one of Me, n-Pr or Ph; r2Is n-Am oriPr; ar is Me, OMe, F, Cl, Br, Ph or CF3Any one substituted benzene ring; wherein Rh (III) is a catalyst.
And after the reaction is finished, separating and purifying the solution after the reaction is finished to obtain the hetero-condensed ring aromatic hydrocarbon compound 3.
The reaction temperature is 80-120 ℃ in the reaction process, and the reaction time is 6-12 h.
The catalyst comprises a rhodium catalyst and a silver salt; the molar ratio of rhodium catalyst to silver salt is 1: 4; the rhodium catalyst is any one or combination of dichloro (pentamethylcyclopentadienyl) rhodium dimer, pentamethylcyclopentadienyl rhodium acetate or bis (hexafluoroantimonate) triethylenenitrile (pentamethylcyclopentadienyl) rhodium; the silver salt is any one or combination of silver hexafluoroantimonate, silver tetrafluoroborate, silver bistrifluoromethanesulfonimide, silver trifluoromethanesulfonate, silver sulfate, silver acetate and silver trifluoroacetate.
The catalyst consists of dichloro (pentamethyl cyclopentadienyl) rhodium dimer and silver hexafluoroantimonate; the molar ratio of dichloro (pentamethylcyclopentadienyl) rhodium dimer to silver hexafluoroantimonate was 1: 4.
the additive is any one or combination of 2,4, 6-trimethyl benzoic acid, pivalic acid, acetic acid, 1-adamantane formic acid, zinc acetate, sodium carbonate, potassium acetate and potassium carbonate.
The solvent is any one or combination of Dichloroethane (DCE), methanol (MeOH), acetonitrile (MeCN), 1,4-dioxane (1,4-dioxane) or toluene (tolumene).
The inert atmosphere is nitrogen atmosphere, and helium, neon, argon and other gas atmospheres can also be used.
The molar ratio of the oxazine compound 1, the diazo compound 2, the catalyst, the additive and the solvent is as follows: 1:(2-3):(0.02-0.04):(0.08-0.16).
The concentration of the reaction system in the solvent is 0.05M-0.2M.
The reaction mode of this reaction is shown in FIG. 31: firstly, a cyclometal intermediate A is obtained through the action of a substrate 1a and a catalyst, then a nitrogen-filled compound and the intermediate A act to obtain an intermediate B, the intermediate B is subjected to carbene migration and insertion to obtain an intermediate C, then metal removal is carried out to obtain an intermediate D, the intermediate D is subjected to the above process again to obtain a double-alkylated intermediate E, the intermediate E is rapidly converted into an enol form F, hydroxyl in the intermediate F attacks an imine bond to obtain an intermediate G, NH in the intermediate G carries out nucleophilic addition-elimination on carbonyl of another molecule to obtain an intermediate I, and then the intermediate I is subjected to continuous conversion such as acidification-ring opening-ring closing-dehydration to obtain the target nitrogen and oxa-condensed ring aromatic hydrocarbon 3 aa.
The invention has the beneficial effects that: the invention creatively selects simple and easily obtained oxazine compounds and diazo compounds as reactants, takes imine in the oxazine compounds as weak reactive type positioning group under the action of a metal rhodium catalyst, and realizes the construction of novel nitrogen and oxygen fused ring aromatic hydrocarbon frameworks in one step by a continuous [4+2] series strategy, the method has simple operation, obvious atom economy and step economy, provides a simple and effective method for the synthesis of hetero fused ring aromatic hydrocarbon, and the method has mild reaction conditions and the reaction temperature of 80-120 ℃; in addition, the yield of the prepared nitrogen and oxygen-containing polycyclic aromatic hydrocarbon is good, and the yield is generally over 80 percent and reaches 98 percent at most. The obtained product has wide industrial application prospect, and provides a new idea and a new method for the fields of medicine, natural product synthesis, luminescent materials and the like.
Drawings
In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings used in the description of the embodiments or the prior art will be briefly described below, it is obvious that the drawings in the following description are only some embodiments of the present invention, and for those skilled in the art, other drawings can be obtained according to the drawings without creative efforts.
FIG. 1 is nuclear magnetism of Compound 3aa1H, spectrogram; FIG. 2 nuclear magnetism of Compound 3aa13And C, spectrum.
FIG. 3 nuclear magnetism of Compound 3ba1H, spectrogram; FIG. 4 nuclear magnetism of Compound 3ba13And C, spectrum.
FIG. 5 shows nuclear magnetism of Compound 3ca1H, spectrogram; FIG. 6 shows nuclear magnetism of Compound 3ca13And C, spectrum.
FIG. 7 nuclear magnetism of Compound 3da1H, spectrogram; FIG. 8 nuclear magnetism of Compound 3da13And C, spectrum.
FIG. 9 is nuclear magnetism of Compound 3ea1H, spectrogram; FIG. 10 is nuclear magnetism of Compound 3ea13And C, spectrum.
FIG. 11 is nuclear magnetism of compound 3fa1H, spectrogram; FIG. 12 nuclear magnetism of Compound 3fa13And C, spectrum.
FIG. 13 nuclear magnetism of Compound 3ga1H, spectrogram; FIG. 14 nuclear magnetism of Compound 3ga13And C, spectrum.
FIG. 15 is nuclear magnetism of compound 3ha1H, spectrogram; FIG. 16 is nuclear magnetism of compound 3ha13And C, spectrum.
FIG. 17 is nuclear magnetism of Compound 3ia1H, spectrogram; FIG. 18 is nuclear magnetism of Compound 3ia13And C, spectrum.
FIG. 19 Nuclear magnetism of Compound 3ja1H, spectrogram; FIG. 20 Nuclear magnetism of Compound 3ja13And C, spectrum.
FIG. 21 nuclear magnetism of Compound 3ka1H, spectrogram; FIG. 22 is nuclear magnetism of compound 3ka13And C, spectrum.
FIG. 23 NMR of Compound 3ab1H, spectrogram; FIG. 24 NMR of Compound 3ab13And C, spectrum.
FIG. 25 nuclear magnetism of Compound 3ac1H, spectrogram; FIG. 26 nuclear magnetism of Compound 3ac13And C, spectrum.
FIG. 27 NMR of Compound 3ad1H, spectrogram; FIG. 28 is nuclear magnetism of Compound 3ad13And C, spectrum.
FIG. 29 Nuclear magnetism of Compound 3ae1H, spectrogram; FIG. 30 NMR of Compound 3ae13And C, spectrum.
FIG. 31 is a diagram showing the reaction mechanism of the present invention.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the drawings in the embodiments of the present invention, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be obtained by a person skilled in the art based on the embodiments of the present invention without inventive step, are within the scope of the present invention.
Example 1
Figure BDA0003652662540000041
Under the condition of nitrogen, 3-aryl benzoxazine compound 1a (0.20mmol), diazo compound 2a (0.44mmol), [ Cp + RhCl2]2(4mol%),AgSbF6(16 mol%), MesCOOH (0.4mmol) and solvent DCE (2.0mL) were added into a 10mL sealed tube, reacted in an 80 ℃ reaction block for 10h, after the reaction was completed, the solvent was removed under reduced pressure, and the desired product, 5, 12-dimethylisoquinoline [2,1,8-mna ], was isolated on a silica gel column]Diethylphenoxazine-4, 13-dicarboxylate (3aa), all eluents were petroleum ether ethyl acetate and dichloromethane at 30: 1: 1, is prepared according to the proportion of 1. And (3) product data characterization: tan liquid, 78% yield. The nuclear magnetic spectrum of the product is shown in figures 1 and 2,1H NMR(400MHz,CDCl3)δ7.23(d,J=8.6Hz,1H),7.11(t,J=8.0Hz,1H),7.03–6.97(m,1H),6.94(t,J=7.6Hz,1H),6.89(d,J=7.7Hz,1H),6.82(d,J=7.9Hz,1H),6.77(d,J=7.3Hz,1H),4.49–4.38(m,4H),2.33(s,6H),1.45–1.40(m,6H).13CNMR(101MHz,CDCl3)δ168.6,167.7,150.6,138.6,137.1,131.2,130.2,129.1,128.4,127.7,125.8,125.7,125.0,123.9,123.6,120.1,119.6,117.1,116.8,115.2,61.1,61.0,19.0,14.4,14.3,13.2.HRMS:[M+H]+calculated for C26H24NO5 +:430.1649,found:430.1635.
example 2
Figure BDA0003652662540000051
Under the condition of nitrogen, 3-aryl benzoxazine compound 1b (0.20mmol), diazo compound 2a (0.44mmol), [ Cp + RhCl2]2(4mol%),AgSbF6(16 mol%), MesCOOH (0.4mmol) and solvent DCE (2.0mL) were added into a 10mL sealed tube, reacted in a 80 ℃ reaction block for 10h, after the reaction was completed, the solvent was removed under reduced pressure, and the desired product, 7-bromo-5, 12-dimethylisoquinoline [2,1,8-mna ], was isolated on a silica gel column]Diethylphenoxazine-4, 13-dicarboxylate (3ba) all eluents were petroleum ether ethyl acetate and dichloromethane at 30: 1: 1, is prepared according to the proportion of 1. And (3) product data characterization: tan solid, 98% yield, melting range: 119-120 ℃. The nuclear magnetic spectrum of the product is shown in figures 3 and 4,1H NMR(400MHz,CDCl3)δ7.26(t,J=8.3Hz,2H),7.14(t,J=8.0Hz,1H),6.86(t,J=8.0Hz,1H),6.79(dd,J=7.5,4.6Hz,2H),4.49–4.39(m,4H),2.44(s,3H),2.33(s,3H),1.45–1.40(m,6H).13C NMR(101MHz,CDCl3)δ168.6,167.6,147.7,138.0,137.1,132.0,131.0,129.2,128.8,128.7,128.0,126.3,124.7,124.6,124.0,120.6,118.5,117.6,115.7,111.2,61.3,61.2,19.0,14.4,14.4,13.5.HRMS:[M+H]+calculated for C26H23BrNO5 +:508.0754,found:508.0717.
example 3
Figure BDA0003652662540000052
Under the condition of nitrogen, 3-aryl benzoxazine compound 1c (0.20mmol), diazo compound 2a (0.44mmol), [ Cp + RhCl2]2(4mol%),AgSbF6(16 mol%), MesCOOH (0.4mmol) and solvent DCE (2.0mL) were added into a 10mL sealed tube, reacted in a 80 ℃ reaction block for 10h, after the reaction was completed, the solvent was removed under reduced pressure, and the desired product, 8-fluoro-5, 12-dimethylisoquinoline [2,1,8-mna ], was isolated on a silica gel column]Diethylphenoxazine-4, 13-dicarboxylate (3ca) was added to the eluent petroleum ether ethyl acetate and dichloromethane at 30: 1: 1, is prepared according to the proportion of 1. Product data characterization: yellow solid, 89% yield, melting range: 104-105 ℃. The nuclear magnetic spectrum of the product is shown in figures 5 and 6,1H NMR(400MHz,CDCl3)δ7.26(t,J=8.3Hz,2H),7.14(t,J=8.0Hz,1H),6.86(t,J=8.0Hz,1H),6.79(dd,J=7.5,4.6Hz,2H),4.49–4.39(m,4H),2.44(s,3H),2.33(s,3H),1.45–1.40(m,6H).13C NMR(101MHz,CDCl3)δ168.6,167.6,147.7,138.0,137.1,132.0,131.0,129.2,128.8,128.7,128.0,126.3,124.7,124.6,124.0,120.6,118.5,117.6,115.7,111.2,61.3,61.2,19.0,14.4,14.4,13.5.HRMS:[M+Na]+calculated for C26H22FNNaO5 +:470.1374,found:470.1371.
example 4
Figure BDA0003652662540000061
Under the condition of nitrogen, 3-aryl benzoxazine compound 1d (0.20mmol), diazo compound 2a (0.44mmol), [ Cp + RhCl2]2(4mol%),AgSbF6(16 mol%), MesCOOH (0.4mmol) and solvent DCE (2.0mL) were added into a 10mL sealed tube, reacted in an 80 ℃ reaction block for 10h, after the reaction was completed, the solvent was removed under reduced pressure, and the desired product, 8-chloro-5, 12-dimethylisoquinoline [2,1,8-mna ], was isolated on a silica gel column]Diethylphenoxazine-4, 13-dicarboxylate (3da), all eluents were petroleum ether ethyl acetate and dichloromethane at 30: 1: 1, is prepared according to the proportion of 1. And (3) product data characterization: tan solid, 82% yield, melting range: 127 ℃ and 128 ℃. Nuclear magnetic resonance of the productThe maps are shown in figures 7 and 8,1H NMR(400MHz,CDCl3)δ7.21(d,J=8.6Hz,1H),7.15–7.06(m,1H),6.98–6.89(m,2H),6.74(t,J=7.6Hz,2H),4.46–4.36(m,4H),2.30(s,3H),2.29(s,3H),1.43-1.38(m,6H).13C NMR(101MHz,CDCl3)13C NMR(101MHz,CDCl3)δ168.6,167.7,151.2,138.0,136.8,131.1,130.9,129.2,128.9,128.6,128.0,125.9,124.9,124.0,123.9,120.4,119.9,117.7,117.3,115.6,61.4,61.2,19.0,14.5,14.4,13.3.HRMS:[M+H]+calculated for C26H23ClNO5 +:464.1259,found:464.1244.
example 5
Figure BDA0003652662540000071
Under the condition of nitrogen, 3-aryl benzoxazine compound 1e (0.20mmol), diazo compound 2a (0.44mmol), [ Cp + RhCl2]2(4mol%),AgSbF6(16 mol%), MesCOOH (0.4mmol) and solvent DCE (2.0mL) were added into a 10mL sealed tube, reacted in a 80 ℃ reaction block for 10h, after the reaction was completed, the solvent was removed under reduced pressure, and the desired product, 8-bromo-5, 12-dimethylisoquinoline [2,1,8-mna ], was isolated on a silica gel column]Diethylphenoxazine-4, 13-dicarboxylate (3ea), all eluents were petroleum ether ethyl acetate and dichloromethane at 30: 1: 1, is prepared according to the proportion of 1. And (3) product data characterization: yellow solid, 89% yield, melting range: 144 ℃ and 145 ℃. The nuclear magnetic spectrum of the product is shown in figures 9 and 10,1H NMR(400MHz,CDCl3)δ7.20(d,J=8.6Hz,1H),7.13–7.00(m,3H),6.74(d,J=7.2Hz,1H),6.64(d,J=8.4Hz,1H),4.46–4.35(m,4H),2.28(s,3H),2.27(s,3H),1.40(td,J=7.1,5.2Hz,6H).13C NMR(101MHz,CDCl3)δ168.5,167.6,151.2,137.9,136.8,130.8,129.6,128.8,128.5,127.9,126.9,125.8,124.8,123.9,120.4,120.4,120.2,118.3,117.3,115.6,61.3,61.2,18.9,14.4,14.4,13.2.HRMS:[M+Na]+calculated for C26H22BrNNaO5 +=530.0574,found:530.0564.
example 6
Figure BDA0003652662540000072
Under the condition of nitrogen, 3-aryl benzoxazine compound 1f (0.20mmol), diazo compound 2a (0.44mmol), [ Cp + RhCl2]2(4mol%),AgSbF6(16 mol%), MesCOOH (0.4mmol) and solvent DCE (2.0mL) were added into a 10mL sealed tube, reacted in an 80 ℃ reaction block for 10h, after the reaction was completed, the solvent was removed under reduced pressure, and the desired product, 8-methyl-5, 12-dimethylisoquinoline [2,1,8-mna ], was isolated on a silica gel column]Diethylphenoxazine-4, 13-dicarboxylate (3fa), all eluents were petroleum ether ethyl acetate and dichloromethane at 30: 1: 1, is prepared according to the proportion of 1. And (3) product data characterization: yellow solid, 77% yield, melting range: 100-101 ℃. The nuclear magnetic spectrum of the product is shown in figures 11 and 12,1H NMR(400MHz,CDCl3)δ7.18(d,J=8.6Hz,1H),7.08(t,J=8.0Hz,1H),6.78–6.68(m,4H),4.48–4.34(m,4H),2.31(s,3H),2.31(s,3H),2.26(s,3H),1.40(td,J=7.1,3.7Hz,6H).13C NMR(101MHz,CDCl3)δ168.8,168.0,150.6,139.0,137.1,136.1,131.4,129.3,128.4,127.8,127.5,125.9,125.1,124.4,123.4,120.0,119.4,117.9,116.2,115.1,61.2,61.0,20.7,19.2,14.5,14.4,13.3.HRMS:[M+Na]+calculated for C27H25NNaO5 +=466.1625,found:466.1617.
example 7
Figure BDA0003652662540000081
Under the nitrogen condition, 1g (0.20mmol) of 3-aryl benzoxazine compound, 2a (0.44mmol) of diazo compound, [ Cp + RhCl2]2(4mol%),AgSbF6(16 mol%), MesCOOH (0.4mmol) and solvent DCE (2.0mL) were added into a 10mL sealed tube, reacted in a 80 ℃ reaction block for 10h, after the reaction was completed, the solvent was removed under reduced pressure, and the desired product, 9-bromo-5, 12-dimethylisoquinoline [2,1,8-mna ], was isolated on a silica gel column]Phenoxazine-4, 13-dicarboxylic acid diethyl ester(3ga), all eluents were petroleum ether ethyl acetate and dichloromethane at 30: 1: 1, is prepared according to the proportion of 1. And (3) product data characterization: yellow solid, 91% yield, melting range: 132 ℃ and 133 ℃. The nuclear magnetic spectrum of the product is shown in figures 13 and 14,1H NMR(400MHz,CDCl3)δ7.21(d,J=8.6Hz,1H),7.13–7.08(m,2H),6.94(d,J=1.6Hz,1H),6.77–6.74(m,2H),4.45–4.37(m,4H),2.31(s,3H),2.30(s,3H),1.43–1.39(m,6H).13C NMR(101MHz,CDCl3)δ168.6,167.6,149.8,137.6,137.1,131.8,130.7,128.7,128.4,128.4,128.0,125.9,124.8,124.2,122.3,120.6,118.3,117.9,116.3,115.8,61.4,61.3,18.9,14.5,14.4,13.3.HRMS:[M+H]+calculated for C26H23BrNO5 +=508.0754,found:508.0747.
example 8
Figure BDA0003652662540000082
Under the nitrogen condition, 1h (0.20mmol) of 3-aryl benzoxazine compound, 2a (0.44mmol) of diazo compound and [ Cp & RhCl ] are added2]2(4mol%),AgSbF6(16 mol%), MesCOOH (0.4mmol) and solvent DCE (2.0mL) were added into a 10mL sealed tube, reacted in an 80 ℃ reaction block for 10h, after the reaction was completed, the solvent was removed under reduced pressure, and the desired product, 9-methoxy-5, 12-dimethylisoquinoline [2,1,8-mna ], was isolated on a silica gel column]Diethylphenoxazine-4, 13-dicarboxylate (3ha) was added to all eluents petroleum ether ethyl acetate and dichloromethane at 30: 1: 1 in proportion. And (3) product data characterization: yellow solid, 53% yield, melting range: 162 ℃ and 163 ℃. The nuclear magnetic spectrum of the product is shown in figures 15 and 16,1H NMR(400MHz,CDCl3)δ7.20(d,J=8.3Hz,1H),7.14–7.04(m,1H),6.80(d,J=8.8Hz,1H),6.74(d,J=7.0Hz,1H),6.52(dd,J=8.8,2.6Hz,1H),6.39(d,J=2.7Hz,1H),4.46–4.36(m,4H),2.34(s,3H),2.31(s,3H),1.42–1.38(m,6H).13C NMR(101MHz,CDCl3)δ168.7,167.8,156.2,144.2,138.4,137.6,131.0,130.9,128.9,128.2,127.6,125.9,125.0,123.7,120.3,117.0,115.3,109.4,106.6,61.2,61.1,55.9,19.2,14.4,14.4,13.3.HRMS:[M+H]+calculated for C27H26NO6 +=460.1755,found:460.1753.
example 9
Figure BDA0003652662540000091
Under the condition of nitrogen, 3-aryl benzoxazine compound 1i (0.20mmol), diazo compound 2a (0.44mmol), [ Cp + RhCl2]2(4mol%),AgSbF6(16 mol%), MesCOOH (0.4mmol) and solvent DCE (2.0mL) are added into a 10mL sealed tube, the mixture reacts in a reaction module of 80 ℃ for 10h, the solvent is removed under reduced pressure after the reaction is finished, and the target product 2-fluoro-5, 12-dimethylisoquinoline [2,1,8-mna ] is obtained by silica gel column separation]Diethylphenoxazine-4, 13-dicarboxylate (3ia), all eluents were petroleum ether ethyl acetate and dichloromethane at 30: 1: 1, is prepared according to the proportion of 1. Product data characterization: yellow solid, 82% yield, melting range: 162 ℃ and 163 ℃. The nuclear magnetic spectrum of the product is shown in figures 17 and 18,1H NMR(400MHz,CDCl3)δ7.07–7.03(m,1H),7.00–6.96(m,1H),6.92(dd,J=7.9,1.5Hz,1H),6.88(dd,J=11.4,2.0Hz,1H),6.85(dd,J=8.0,1.2Hz,1H),6.61(dd,J=10.2,2.0Hz,1H),4.46–4.37(m,4H),2.37(s,3H),2.32(s,3H),1.43–1.39(m,6H).13C NMR(101MHz,CDCl3)δ168.2,167.1,162.6(d,J=243.1Hz),150.7,140.8,136.6,131.9(d,J=11.2Hz),131.3,129.6,129.5,127.3,126.2,123.9,122.8(d,J=5.4Hz),122.2,120.0,117.3,115.5,105.4(d,J=29.2Hz),103.8(d,J=24.6Hz),61.2,61.2,19.4,14.4,14.3,13.4.HRMS:[M+H]+calculated for C26H23FNO5 +=448.1555,found:448.1539.
example 10
Figure BDA0003652662540000092
Under the condition of nitrogen, 3-aryl benzoxazine compound 1j (0.20mmol), diazo compound 2a (0.44mmol), [ Cp ] RhCl2]2(4mol%),AgSbF6(16 mol%), MesCOOH (0.4mmol) and solvent DCE (2.0mL) are added into a 10mL sealed tube, the mixture reacts in a reaction module of 80 ℃ for 10h, the solvent is removed under reduced pressure after the reaction is finished, and the target product 2-bromo-5, 12-dimethylisoquinoline [2,1,8-mna ] is obtained by silica gel column separation]Phenoxazine-4, 13-dicarboxylic acid diethyl ester (3ja), all eluents were petroleum ether ethyl acetate and dichloromethane at 30: 1: 1, is prepared according to the proportion of 1. And (3) product data characterization: yellow solid, 87% yield, melting range: 142 ℃ and 143 ℃. The nuclear magnetic spectrum of the product is shown in figures 19 and 20,1H NMR(400MHz,CDCl3)δ7.39d,J=1.5Hz,1H),7.10–7.05(m,1H),7.03–7.01(m,1H),6.94(dd,J=7.8,1.5Hz,1H),6.89–6.84(m,2H),4.49–4.39(m,4H),2.38(s,3H),2.34(s,3H),1.45–1.42(m,6H).13C NMR(101MHz,CDCl3)δ168.1,167.2,150.7,140.5,137.4,131.3,131.0,129.7,129.4,127.0,126.3,124.2,123.6,122.8,122.1,120.0,118.4,117.4,115.4,77.2,61.4,61.3,19.4,14.4,14.4,13.4.HRMS:[M+H]+calculated for C26H23BrNO5 +=508.0754,found:508.0742.
example 11
Figure BDA0003652662540000101
Under the nitrogen condition, 3-aryl benzoxazine compound 1k (0.20mmol), diazo compound 2a (0.44mmol), [ Cp × RhCl2]2(4mol%),AgSbF6(16 mol%), MesCOOH (0.4mmol) and solvent DCE (2.0mL) are added into a 10mL sealed tube, the mixture reacts in a reaction module of 80 ℃ for 10h, the solvent is removed under reduced pressure after the reaction is finished, and the target product, 2-methoxy-5, 12-dimethyl isoquinoline [2,1,8-mna ], is obtained by silica gel column separation]Phenoxazine-4, 13-dicarboxylic acid diethyl ester (3ka), all eluents were petroleum ether ethyl acetate and dichloromethane at 30: 1: 1, is prepared according to the proportion of 1. And (3) product data characterization: red solid, 77% yield, melting range: 172 ℃ and 173 ℃. The nuclear magnetic spectrum of the product is shown in figures 21 and 22,1H NMR(400MHz,CDCl3)δ7.52(s,1H),7.08(t,J=7.7Hz,1H),7.03–6.99(m,1H),6.95–6.93(m,2H),6.88–6.86(d,J=7.4Hz,1H),4.49(q,J=7.1Hz,1H),4.43(q,J=7.2Hz,1H),2.39(s,3H),2.36(s,3H),1.45–1.41(m,6H).13C NMR(101MHz,CDCl3)δ167.9,167.2,150.5,140.9,138.7,131.1,130.7,129.7(q,J=31.8Hz),129.5,127.3,126.3,126.2,124.7,124.3,124.2(q,J=272.7Hz),120.0,117.7(dd,J=9.2),117.7(d,J=4.7Hz),117.4,115.7,110.8(d,J=3.2Hz).61.5,61.3,19.5,14.3,14.3,13.3.HRMS:[M+H]+calculated for C27H23F3NO5 +=498.1523,found:498.1508.
example 12
Figure BDA0003652662540000111
Under the condition of nitrogen, 3-aryl benzoxazine compound 1a (0.20mmol), diazo compound 2b (0.44mmol), [ Cp + RhCl2]2(4mol%),AgSbF6(16 mol%), MesCOOH (0.4mmol) and solvent DCE (2.0mL) were added into a 10mL sealed tube, reacted in an 80 ℃ reaction block for 10h, after the reaction was completed, the solvent was removed under reduced pressure, and the desired product, 5, 12-dimethylisoquinoline [2,1,8-mna ], was isolated on a silica gel column]Phenoxazine-4, 13-dicarboxylic acid dipentyl ester (3ab) with all eluents petroleum ether ethyl acetate and dichloromethane at 30: 1: 1 in proportion. And (3) product data characterization: yellow liquid, 96% yield. The nuclear magnetic spectrum of the product is shown in figures 23 and 24,1H NMR(400MHz,CDCl3)δ7.23–7.15(m,1H),7.09(t,J=7.9Hz,1H),7.03(t,J=7.4Hz,1H),6.99–6.95(m,1H),6.91(dd,J=7.7,1.6Hz,1H),6.84(d,J=7.7Hz,1H),6.79–6.67(m,1H),4.36(t,J=6.7Hz,3H),4.31(t,J=6.8Hz,3H),2.32(s,3H),2.31(s,3H),1.80–1.73(m,4H),1.43–1.36(m,8H),0.95–0.90(m,6H).13C NMR(101MHz,CDCl3)δ168.9,168.0,150.7,138.6,137.2,131.3,130.3,129.2,128.4,127.8,125.9,125.8,125.1,124.0,123.7,120.2,119.7,117.2,116.9,115.3,65.4,65.3,28.5,28.4,28.3,28.3,22.4,22.4,19.1,14.1,14.1,13.3.HRMS:[M+H]+calculated for C32H36NO5 +=514.2588,found:514.2577.
example 13
Figure BDA0003652662540000112
Under the condition of nitrogen, 3-aryl benzoxazine compound 1a (0.20mmol), diazo compound 2c (0.44mmol), [ Cp + RhCl2]2(4mol%),AgSbF6(16 mol%), MesCOOH (0.4mmol) and solvent DCE (2.0mL) were added into a 10mL sealed tube, reacted in an 80 ℃ reaction block for 10h, after the reaction was completed, the solvent was removed under reduced pressure, and the desired product, 5, 12-dimethylisoquinoline [2,1,8-mna ], was isolated on a silica gel column]Phenoxazine-4, 13-dicarboxylic acid diisopropyl ester (3ac) and all eluents were petroleum ether ethyl acetate and dichloromethane at 30: 1: 1 in proportion. Product data characterization: red liquid, 80% yield. The nuclear magnetic spectrum of the product is shown in figures 25 and 26,1H NMR(400MHz,CDCl3)δ7.24(d,J=23.1Hz,1H),7.16–7.07(m,1H),7.02–6.89(m,3H),6.84–6.80(m,1H),6.75–6.70(m,1H),5.39–5.28(m,2H),2.33(s,6H),1.44–1.36(m,12H).13C NMR(101MHz,CD Cl3)δ168.1,167.2,150.5,137.9,137.1,131.1,130.2,129.1,128.2,127.7,125.6,125.4,125.0,123.9,119.9,119.5,117.1,114.9,68.8,68.7,22.0,21.9,18.9,13.1.HRMS:[M+H]+calculated for C28H28NO5 +=458.1962,found:458.1943.
example 14
Figure BDA0003652662540000121
Under the condition of nitrogen, 3-aryl benzoxazine compound 1a (0.20mmol), diazo compound 2d (0.44mmol), [ Cp + RhCl2]2(4mol%),AgSbF6(16mol percent), MesCOOH (0.4mmol) and a solvent DCE (2.0mL) are added into a 10mL sealed tube and reacted for 10 hours in a reaction module with the temperature of 80 ℃, the solvent is removed under reduced pressure after the reaction is finished, and the target product 5, 12-diethylisoquinoline is obtained by silica gel column separationQuinoline [2,1,8-mna ]]Phenoxazine-4, 13-dicarboxylic acid dimethyl ester (3ad), all eluents were petroleum ether ethyl acetate and dichloromethane at 30: 1: 1, is prepared according to the proportion of 1. And (3) product data characterization: yellow liquid, 60% yield. The nuclear magnetic spectrum of the product is shown in figures 27 and 28,1H NMR(400MHz,CDCl3)δ7.17(t,J=8.5Hz,1H),7.13–7.08(m,1H),7.07–7.03(m,1H),7.01–6.95(m,1H),6.94–6.88(m,2H),6.70(d,J=7.1Hz,1H),3.94(s,3H),3.91(s,3H),2.81–2.74(m,2H),2.69(dd,J=8.7,6.8Hz,2H),1.71–1.52(m,4H),0.99(t,J=7.4Hz,3H),0.94(t,J=7.3Hz,3H).13C NMR(101MHz,CDCl3)δ169.3,168.5,150.7,142.8,137.4,132.2,131.6,130.9,129.0,128.5,127.8,125.7,124.9,124.1,123.1,120.8,119.3,118.2,117.3,115.6,52.2,52.2,32.4,30.2,23.9,22.8,14.5,13.9.HRMS:[M+H]+calculated for C28H28NO5 +=458.1962,found:458.1949.
example 15
Figure BDA0003652662540000122
Under the nitrogen condition, 3-aryl benzoxazine compound 1a (0.20mmol), diazo compound 2e (0.44mmol), [ Cp × RhCl2]2(4mol%),AgSbF6(16 mol%), MesCOOH (0.4mmol) and solvent DCE (2.0mL) were added into a 10mL sealed tube, reacted in a 80 ℃ reaction block for 10h, after the reaction was completed, the solvent was removed under reduced pressure, and the desired product, 5, 12-dipropylisoquinoline [2,1,8-mna ], was isolated by silica gel column]Phenoxazine-4, 13-dicarboxylic acid dimethyl ester (3ae), all eluents were petroleum ether ethyl acetate and dichloromethane at 30: 1: 1, is prepared according to the proportion of 1. And (3) product data characterization: yellow liquid, 63% yield. The nuclear magnetic spectrum of the product is shown in figures 29 and 30,1H NMR(400MHz,CDCl3)δ7.19(dd,J=8.6,0.7Hz,1H),7.13–7.09(m,1H),7.07–7.03(m,1H),7.00–6.96(m,1H),6.93(dd,J=7.8,1.5Hz,0H),6.90(dd,J=7.9,1.4Hz,1H),6.70(dd,J=7.2,0.7Hz,1H),3.94(s,3H),3.91(s,3H),2.82–2.79(m,2H),2.76–2.65(m,2H),1.65–1.51(m,4H),1.48–1.39(m,2H),1.37–1.32(m,2H),0.96(t,J=7.3Hz,3H),0.85(t,J=7.3Hz,3H).13C NMR(101MHz,CDCl3)δ169.3,168.5,150.7,143.1,137.4,132.2,131.6,131.2,129.1,128.5,127.7,125.7,124.8,124.1,123.0,120.7,119.3,118.1,117.2,115.5,52.2,52.1,32.7,31.5,30.1,27.9,23.0,22.4,14.1,13.8.HRMS:[M+H]+calculated for C30H32NO5 +=486.2275,found:486.2266.
the above description is only for the purpose of illustrating the preferred embodiments of the present invention and is not to be construed as limiting the invention, and any modifications, equivalents, improvements and the like that fall within the spirit and principle of the present invention are intended to be included therein.

Claims (10)

1. A nitrogen and oxygen fused ring aromatic hydrocarbon is characterized in that the structural formula is as follows:
Figure FDA0003652662530000011
wherein R is any one of H, Me, OMe, F, Cl or Br; r1Any one of Me, n-Pr or Ph; r2Is n-Am oriPr; ar is Me, OMe, F, Cl, Br, Ph or CF3Any substituted benzene ring.
2. A process for the synthesis of nitrogen and oxa-fused ring aromatic hydrocarbons as claimed in claim 1, comprising the steps of: adding an oxazine compound 1, a diazo compound 2, a catalyst and an additive into a solvent in an inert atmosphere for reaction to obtain a hetero-condensed ring aromatic compound 3 after the reaction is finished, wherein the reaction equation is as follows:
Figure FDA0003652662530000012
wherein R is any one of H, Me, OMe, F, Cl or Br; r1Any one of Me, n-Pr or Ph; r2Is n-Am oriPr;Ar is Me, OMe, F, Cl, Br, Ph or CF3Any substituted benzene ring.
3. The method for synthesizing nitrogen-and oxa-condensed ring aromatic hydrocarbons according to claim 2, wherein: the reaction temperature is 80-120 ℃ in the reaction process, and the reaction time is 6-12 h.
4. A method for synthesizing nitrogen-and oxa-condensed ring aromatic hydrocarbons according to claim 2 or 3, wherein: the catalyst comprises a rhodium catalyst and a silver salt; the molar ratio of rhodium catalyst to silver salt is 1: 4; the rhodium catalyst is any one or combination of dichloro (pentamethylcyclopentadienyl) rhodium dimer, pentamethylcyclopentadienyl rhodium acetate or bis (hexafluoroantimonate) triethylenenitrile (pentamethylcyclopentadienyl) rhodium; the silver salt is any one or combination of silver hexafluoroantimonate, silver tetrafluoroborate, silver bistrifluoromethanesulfonimide, silver trifluoromethanesulfonate, silver sulfate, silver acetate and silver trifluoroacetate.
5. The method for synthesizing nitrogen-and oxa-condensed ring aromatic hydrocarbons according to claim 4, wherein: the catalyst consists of dichloro (pentamethyl cyclopentadienyl) rhodium dimer and silver hexafluoroantimonate; the molar ratio of dichloro (pentamethylcyclopentadienyl) rhodium dimer to silver hexafluoroantimonate was 1: 4.
6. the method for synthesizing nitrogen-and oxa-condensed ring aromatic hydrocarbons according to claim 5, wherein: the additive is any one or combination of 2,4, 6-trimethyl benzoic acid, pivalic acid, acetic acid, 1-adamantane formic acid, zinc acetate, sodium carbonate, potassium acetate or potassium carbonate.
7. The method for synthesizing nitrogen-and oxa-condensed ring aromatic hydrocarbons according to claim 6, wherein: the solvent is any one or combination of dichloroethane, methanol, acetonitrile, 1,4-dioxane or toluene.
8. A method of synthesizing nitrogen and oxa-polycyclic aromatic hydrocarbons according to any one of claims 5 to 7, wherein: the inert atmosphere is nitrogen atmosphere.
9. The method as recited in claim 8, wherein the nitrogen-and oxygen-containing condensed ring aromatic hydrocarbon is synthesized by: the molar ratio of the oxazine compound 1, the diazo compound 2, the catalyst, the additive and the solvent is as follows: 1:(2-3):(0.02-0.04):(0.08-0.16).
10. The method for synthesizing nitrogen-and oxa-condensed ring aromatic hydrocarbons according to claim 9, wherein: the concentration of the reaction system in the solvent is 0.05M-0.2M.
CN202210557098.5A 2022-05-19 2022-05-19 Nitrogen and oxa condensed ring aromatic hydrocarbon and synthetic method thereof Withdrawn CN114716454A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CN202210557098.5A CN114716454A (en) 2022-05-19 2022-05-19 Nitrogen and oxa condensed ring aromatic hydrocarbon and synthetic method thereof
CN202310563635.1A CN116836180A (en) 2022-05-19 2023-05-18 Nitrogen and oxygen hetero-polycyclic aromatic hydrocarbon and synthetic method and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202210557098.5A CN114716454A (en) 2022-05-19 2022-05-19 Nitrogen and oxa condensed ring aromatic hydrocarbon and synthetic method thereof

Publications (1)

Publication Number Publication Date
CN114716454A true CN114716454A (en) 2022-07-08

Family

ID=82231236

Family Applications (2)

Application Number Title Priority Date Filing Date
CN202210557098.5A Withdrawn CN114716454A (en) 2022-05-19 2022-05-19 Nitrogen and oxa condensed ring aromatic hydrocarbon and synthetic method thereof
CN202310563635.1A Pending CN116836180A (en) 2022-05-19 2023-05-18 Nitrogen and oxygen hetero-polycyclic aromatic hydrocarbon and synthetic method and application thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN202310563635.1A Pending CN116836180A (en) 2022-05-19 2023-05-18 Nitrogen and oxygen hetero-polycyclic aromatic hydrocarbon and synthetic method and application thereof

Country Status (1)

Country Link
CN (2) CN114716454A (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110167940A (en) * 2017-01-30 2019-08-23 默克专利有限公司 Material for organic electroluminescence device
CN112778307A (en) * 2021-01-21 2021-05-11 北京八亿时空液晶科技股份有限公司 Carbazole derivative and application thereof
WO2021122538A1 (en) * 2019-12-18 2021-06-24 Merck Patent Gmbh Aromatic compounds for organic electroluminescent devices

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110167940A (en) * 2017-01-30 2019-08-23 默克专利有限公司 Material for organic electroluminescence device
WO2021122538A1 (en) * 2019-12-18 2021-06-24 Merck Patent Gmbh Aromatic compounds for organic electroluminescent devices
CN112778307A (en) * 2021-01-21 2021-05-11 北京八亿时空液晶科技股份有限公司 Carbazole derivative and application thereof

Also Published As

Publication number Publication date
CN116836180A (en) 2023-10-03

Similar Documents

Publication Publication Date Title
CN113563370B (en) Preparation method for preparing beta-boron-based ketone with alpha-position substituent by catalysis of chitosan loaded copper material
CN112300201B (en) Synthesis and preparation method of trimeric indenyl coumarin-corrole-porphyrin quaternary system star-shaped compound
CN108558692B (en) Preparation method of amide compound
CN111253409A (en) Macrocyclic extended porphyrin compound containing carbazole unit and preparation method thereof
CN114380675A (en) Method for synthesizing aryl phenol by reaction of halogenated aromatic hydrocarbon and phenol compound induced by visible light
CN114716454A (en) Nitrogen and oxa condensed ring aromatic hydrocarbon and synthetic method thereof
CN112321487A (en) Polysubstituted isoindoline compound and preparation method thereof
CN111533745A (en) Process for preparing tert-butyl-3- (aminomethyl) dihydro-5H-triazolodiazepine-8 (9H) -carboxylic acid ester
Yip et al. Transition metal promoted reactions. 29.(Z)-2, 2'-Disubstituted bifluorenylidenes by intramolecular desulfurdimerization reactions
CN115785135A (en) Polysubstituted prenyl borate and synthesis method thereof
CN111423365B (en) Bifunctional group pillar aromatic hydrocarbon derivative ligand, metal organic cage and preparation method
CN107603271B (en) Preparation method of long-chain alkoxy BODIPY compound
CN112778191A (en) Visible light mediated method for synthesizing allyl alcohol compound containing indole skeleton
CN114524815B (en) 8-alkoxypurine derivative and preparation method and application thereof
CN114874105B (en) Preparation method of visible light and water promoted homoallylic amine compound
CN113845550B (en) Flexible large-steric-hindrance N-heterocyclic carbene palladium complex containing halogenated benzene ring, preparation method and application thereof
CN115260205B (en) Bipyrene-doped extended porphyrin, bipropylar metal complex thereof, preparation method and application thereof
CN113402536B (en) Porphyrin bridged double BODIPY derivative and preparation method thereof
CN111285846B (en) 2- (2-indolyl) -acetate derivative and synthesis method thereof
CN102432425B (en) Preparation method of 1,3-disubstituted-3-aryl propylene compound and application thereof
CN117024499A (en) Preparation method of steroid compound with methylene hydroxyl introduced at 2-position
CN117720467A (en) Preparation method of surface chiral [2.2] cycloquinoline imitation catalyst
CN115260205A (en) Dipyrenyl-doped expanded porphyrin, double-palladium metal complex thereof, preparation method and application thereof
CN117659018A (en) Chiral C1 symmetrical imidazole-pyridine-imidazolidinone tridentate nitrogen ligand, synthesis and application thereof
CN114213256A (en) Preparation method of di (4-biphenyl) amine

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WW01 Invention patent application withdrawn after publication
WW01 Invention patent application withdrawn after publication

Application publication date: 20220708